A recent study conducted at NYU Langone Health, which includes the Perlmutter Cancer Center and the Center for the Investigation of Environmental Hazards, has revealed a significant link between microplastics and prostate cancer. This investigation aims to determine whether exposure to microplastics might play a role in the onset of prostate cancer, recognized by the American Cancer Society as the most prevalent cancer among men in the U.S.
Microplastics and Human Exposure
Microplastics, tiny fragments resulting from the breakdown of plastics used in various products such as food packaging and cosmetics, can infiltrate the human body through several channels, including ingestion, inhalation of contaminated air, and skin contact. Previous studies have found these particles in numerous organs, bodily fluids, and even the placenta, yet the full impact of microplastics on human health remains largely unknown.
Concentration of Plastics in Tumor Samples
The research team analyzed prostate tissue from ten patients who underwent surgery for prostate removal. Remarkably, microplastic particles were present in 90% of tumor samples, compared to 70% in benign tissues. Tumor samples showed an average of 2.5 times more plastic than healthy tissue, with concentrations of about 40 micrograms per gram versus 16 micrograms per gram, respectively.
Lead author Dr. Stacy Loeb, a professor at NYU Grossman School of Medicine, emphasized that this pilot study offers compelling evidence suggesting that microplastic exposure might be a contributing factor to prostate cancer. While previous studies hinted at connections between microplastics and other health issues like heart disease and dementia, direct evidence linking them to prostate cancer had been scarce.
The findings will be presented at the American Society of Clinical Oncology's Genitourinary Cancers Symposium on February 26. This research is notable as it marks the first comprehensive Western study to assess microplastic levels in prostate tumors and compare them with noncancerous tissue.
Meticulous Methodology to Avoid Contamination
To ensure accuracy, the researchers meticulously examined both tumor and benign samples. They employed advanced instruments to analyze the quantity, chemical makeup, and structure of microplastic particles, focusing on twelve prevalent types of plastics. Given the extensive use of plastic in medical environments, the team took stringent measures to prevent contamination by utilizing non-plastic alternatives for their tools and conducting tests in specialized clean rooms.
Investigating the Inflammatory Response
Dr. Vittorio Albergamo, senior author of the study, pointed out the importance of addressing public exposure to microplastics, highlighting the potential health risks they pose. The team plans to further explore how microplastics interact within the body and their possible role in cancer development, particularly considering the potential for these particles to incite a prolonged inflammatory response within prostate tissue, which could lead to cellular damage and genetic alterations over time.
While the study involved a limited number of participants, further research is essential to validate these findings and deepen our understanding of microplastics in health contexts.
Statistics from the Centers for Disease Control and Prevention indicate that approximately one in eight men in the U.S. will receive a prostate cancer diagnosis in their lifetime. The research received funding from the U.S. Department of Defense.
